Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1200/JCO.22.00711 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Author reply regarding "Maternal stress in pregnancy and pubertal timing in girls and boys: a cohort study".
Fertil Steril
October 2024
Department of Public Health, Research Unit for Epidemiology, Aarhus University, Aarhus, Denmark.
Author Reply to "Regarding 'Mid-Term Outcome of Superior Capsular Reconstruction Using Fascia Lata Autograft (At Least 6 mm in Thickness) Results in High Retear Rate and No Improvement in Muscle Strength'".
Arthroscopy
January 2025
Department of Orthopaedic Surgery, Yeosu Baek Hospital, Jeollanam-do, Republic of Korea.
Empirical application of a multidimensional approach to capture a broader assessment of clinical benefits in a heterogenous spine population - author's reply.
EBioMedicine
October 2024
Division of Neurosurgery & Spine Program, Department of Surgery, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Division of Genetics & Development, Krembil Brain Institute, University Health Network, Toronto, ON, Canada; Division of Neurosurgery, Krembil Neuroscience Centre, Toronto Western Hospital, University Health Network, Toronto, ON, Canada. Electronic address:
'I Was Only the Impresario - the Managing Director': J.J.R. Macleod and the Pragmatics of the Discovery and Development of Insulin.
Can J Health Hist
September 2023
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Article Synopsis
- On November 7, 1923, J.J.R. Macleod announced he would share his Nobel Prize with J.B. Collip after F.G. Banting shared his half with C.H. Best.
- Macleod humbly described his role in the discovery of insulin as merely being an "impresario," but his expertise and leadership were critical to the development of insulin as an effective diabetes treatment.
- The consensus is that while his humility is noted, Macleod's significant contributions in research and management were essential for the success of the insulin project.
Reply: Mobile health interventions in multiple sclerosis: A systematic review.
Mult Scler
April 2024
Department of General Practice and Primary Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!